RACGAP1 and hepatocellular carcinoma: NEK2 and RACGAP1 have been shown to be involved in oncogenic pathways and oncogene-regulated processes such as BRCA1- and Wnt-dependent signaling cascades [62], [63], [64], [65], possibly implicating these pathways in the development of HCC.